Clinical Trial Update: Study on Anti-inflammatory Effects of Topical R115866 Gel [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the anti-inflammatory effects of topical R115866 Gel has completed. The study focused on cutaneous inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Inflammation

Drugs mentioned

• Topical R115866 Gel (R115866)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Cutaneous Inflammation | Phase 1 | Status: COMPLETED